Insights

June 12, 2024

Exploring a rare form of Alzheimer’s disease affecting younger individuals

Alzheimer’s disease, the most common form of dementia in the United States, affects millions of Americans, predominately striking after the age of 60. However, there is a lesser-known rare variant of Alzheimer’s called Posterior Cortical Atrophy (PCA) that makes up about 5% of cases. Read now

June 12, 2024

FDA approves the first treatment to reduce the severity of food allergy reactions

For the first time, the FDA has approved a treatment to reduce the severity of dangerous allergic reactions due to accidental exposure to food allergens. Here’s what to know about this new tool to help manage food allergies. Read now

May 22, 2024

Living and thriving as a cancer survivor

Becky, a vibrant and active woman, faced a life-altering diagnosis of Stage IV lung cancer. Guided by PHM's Personal Care Team and the power of molecular profiling, Becky's treatment evolved based on her unique genetic markers, leading to remarkable progress. Read now

April 30, 2024

COVID-19 and its impact on high-risk groups

There have been a few COVID-19 updates in the news in the last month. It is important for people who are at high-risk of serious illness to be aware of these changes, including adults aged 65 years and older, pregnant people, children aged 5 years and under, and people with weakened immune systems due to medical conditions or immunosuppressive treatments. Read now

April 17, 2024

Optimizing Cancer Care and Costs

Natalya Gertsik, PhD, Vice President of ClearCancer Solution, and Tommy Axford, FSA, MAAA, SVP Strategic Partnerships, join Springbuk’s “Healthcare Rocks” podcast to discuss PHM’s cutting-edge solution, ClearCancer, and how employers and advisors are adopting data-driven strategies to address the challenges of high-cost cancer treatments. Listen now

April 15, 2024

How to talk to kids about cancer

At PHM, we advocate for a family-centered approach to care. Alongside our highly skilled advanced practice clinicians, PhD-led research scientists, and expert coordinators, we offer the support of Certified Child Life Specialists in-house. These specialists assist our clients in having difficult conversations with their children following a new cancer diagnosis and prepare them for what emotional or behavioral reactions they can expect. Read now

March 07, 2024

Gene editing-based therapies could revolutionize how genetic diseases are treated

Patients with the debilitating, inherited blood disorders sickle cell anemia and beta-thalassemia recently received news of a life-changing treatment. The FDA approved Casgevy, a groundbreaking therapy that uses a gene editing tool called CRISPR (pronounced ‘crisper’) to treat these disorders. This is the first ever approval for this innovative type of treatment, which can change the DNA code in a patient’s cells to target the underlying cause of a disease. Read now

March 07, 2024

What to know about measles outbreak in the U.S.

Measles cases are on the rise globally, despite the availability of a safe and effective vaccine that prevents the infection. In the U.K., where over 400 cases have been detected since October of 2023,1 the alarming surge has been deemed a “national incident.” As a result, the U.S. Centers for Disease Control (CDC) issued a warning for physicians to be on alert for measles cases. Read now

March 07, 2024

Raising awareness of a rare type of stroke

The American Heart Association (AHA) recently released new analysis and recommendations for the diagnosis and treatment of a…

Read now

March 07, 2024

Early cancer detection is paramount in the relentless battle against cancer

Recent findings from the American Cancer Society’s latest 2024 Cancer Statistics report paint a complex picture: while overall…

Read now

March 07, 2024

PHM’s Evidence-Based Approach Reduces Treatment Uncertainty for Our Patient with Breast Cancer

Many cancer patients are faced with deep, personal decisions about what treatment path will be right for them.…

Read now